XML 24 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2018
Cash flows from operating activities      
Net (loss) income $ (27,236) $ (255) $ 1,712
Adjustments to reconcile net (loss) income to net cash provided by operating activities      
Depreciation of property and equipment 2,945 3,150 3,730
Amortization of Intangible Assets 1,234 296 204
Accounts Receivable, Credit Loss Expense (Reversal) 1,300 125 125
Financing Receivable, Allowance for Credit Loss, Recovery     (225)
Write off of Patent Costs 4,206 800 497
Share-based Payment Arrangement, Noncash Expense 13,612 11,266 10,302
Accretion (Amortization) of Discounts and Premiums, Investments (109) (55) 0
Loss on disposal of property and equipment and other 170 42 16
Changes in assets and liabilities      
Accounts receivable 9,503 (4,915) (2,878)
Inventories (9,648) (1,453) 292
Prepaid expenses and other assets 1,319 (393) 2,308
Accounts payable 576 566 104
Accrued expenses and other liabilities (8,906) 2,918 (6,577)
Deferred revenue (1,731) (1,884) 189
Net cash (used in) provided by operating activities (12,765) 10,208 9,674
Cash flows from investing activities      
Expenditures for property and equipment (3,369) (2,665) (1,956)
Payments To Acquire Intangible Assets Purchased (5,741) 0 0
Payments to Acquire Marketable Securities (750) (3,055) (2,538)
Payments to Acquire Debt Securities, Available-for-sale (38,782) (47,892) 0
Proceeds from Sale and Maturity of Marketable Securities 7,290 150 194
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale 33,400 0 0
Costs incurred in connection with patents (717) (890) (1,113)
Proceeds from convertible note receivable 0 0 318
Net cash used in investing activities (8,669) (54,352) (5,095)
Cash flows from financing activities      
Proceeds from the employee stock purchase plan 4,076 3,752 3,242
Payment of employee taxes related to vested restricted stock (6,303) (1,791) 0
Exercise of stock options 0 196 513
Proceeds from Issuance of Common Stock 134,979 0 0
Principal payments made on financing obligation (92) (36) 14
Net cash provided by financing activities 132,660 2,121 3,769
Net change in cash and cash equivalents 111,226 (42,023) 8,348
Cash and cash equivalents      
Beginning of period 74,237 116,260 107,912
End of period 185,463 74,237 116,260
Supplemental cash flow information      
Interest paid $ 1,659 $ 1,684 $ 1,717